T2 Biosystems Announces First Quarter 2023 Financial Results

LEXINGTON, Mass., May 23, 2023 -- T2 Biosystems, Inc.  , a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced financial results for the... | May 23, 2023

Related Keywords

,John Sperzel ,Lyme Panel ,Biothreat Panel ,Company Annual Report On Form ,Exchange Commission ,Nasdaq ,While The Company ,Gilmartin Group ,Resistance Panel ,Biosystems Inc ,Globenewswire Inc ,Device Designation ,Medical Affairs ,Conference Call ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Current Reports ,Trip Taylor ,T2 Biosystems ,Nc Stock Exchange ,News ,Information ,Press Release ,Bay ,023 ,2 ,Leader ,N ,The ,Rapid ,Detection ,F ,Pathogens ,End ,Ntibiotic ,Resistance ,Oday ,Nnounced ,Financial ,Results ,Or Ttoo Us89853l2034 ,